Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Shionogi's U.S. subsidiary identifies specific antitumor agents with a cyanoguanidine structure

Nov. 17, 2000

Akzo presents new LH receptor agonists and their use in controlling fertility

Nov. 17, 2000

SCRAS issued patent for new series of somatostatin receptor modulators

Nov. 17, 2000

Canadian company presents new HIV integrase inhibitors

Nov. 17, 2000

Research at Pacific leads to identification of potent new antiinflammatory agents

Nov. 17, 2000

Potent and safer antioxidants, and their use, claimed by Jenapharm

Nov. 17, 2000

Therapeutic and diagnostic use of new CD164-binding monoclonal antibody

Nov. 17, 2000

SB's new ET receptor antagonists covered by U.S. patent

Nov. 16, 2000

Naeja describes preparation, activity and use of new cathepsin inhibitors

Nov. 16, 2000

Series of selective Tgamma9delta2 lymphocyte inhibitors emerges from joint U.S.-French R&D

Nov. 16, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...